shutterstock_2094533392_michael_vi
Michael Vi / Shutterstock.com
28 February 2023Muireann Bolger

USPTO told to avoid negative focus on patent thickets

Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
6 September 2022   Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.
Americas
22 April 2021   In a boon for eye care specialist Nicox, the United States Patent and Trademark Office has confirmed that one of its three patents covering a glaucoma treatment could be extended by up to five years.

More on this story

Big Pharma
6 September 2022   Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.
Americas
22 April 2021   In a boon for eye care specialist Nicox, the United States Patent and Trademark Office has confirmed that one of its three patents covering a glaucoma treatment could be extended by up to five years.

More on this story

Big Pharma
6 September 2022   Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.
Americas
22 April 2021   In a boon for eye care specialist Nicox, the United States Patent and Trademark Office has confirmed that one of its three patents covering a glaucoma treatment could be extended by up to five years.